Company Overview
Company Name
Syndax Pharmaceuticals, Inc.
Address
730 3rd Ave #900, New York, NY, 10017, United States
Website
syndax.comPhone
(781) 419-1400Employees
51
Established
2004
About Syndax Pharmaceuticals, Inc.
Syndax is a clinical-stage oncology company based in Waltham, Massachusetts, with approximately 51 employees. The company is focused on developing targeted treatments for acute leukemias and chronic graft-versus-host disease, with two late-stage drug candidates, revumenib and axatilimab, that have the potential to be approved in the U.S. by 2024.
Frequently Asked Questions about Syndax Pharmaceuticals, Inc.
Technologies Used
Social Profiles
Key Decision Makers
Sophia C. Clinical Trial Specialist
Caroline Larisa Clinical Trial Associate
Shaun Ricketts, PMP Clinical Trial Manager, Expanded Access Program and Compassionate Use
Mandy Plemons Clinical Trial Manager, Study Start Up
Christina K. Clinical Trial Manager
Susan Brouwer Senior Clinical Trial Manager